Showing results (711-720 of 791) with videos related to
Sort By:
Pageof 80
Emerging Infectious Diseases|July 24, 2023
Population-Based Serologic Survey of Vibrio cholerae Antibody Titers before Cholera Outbreak, Haiti, 2022Christy H Clutter, Molly B Klarman, Youseline Cajusma, et al.Cancer Research|March 5, 2009
Cancer-specific transgene expression mediated by systemic injection of nanoparticlesEdward J Chisholm, Georges Vassaux, Pilar Martin-Duque, et al.Scientific Reports|March 16, 2016
Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressorsMohamed El-Far, Pascale Kouassi, Mohamed Sylla, et al.Nature Communications|October 24, 2018
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1Salima Daou, Haithem Barbour, Oumaima Ahmed, et al.The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 27, 2007
HIV-associated lipodystrophy syndrome: A review of clinical aspectsJean-Guy Baril, Patrice Junod, Roger Leblanc, et al.The American Journal of Clinical Nutrition|May 16, 2014
DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trialPeter J H Jones, Vijitha K Senanayake, Shuaihua Pu, et al.Plos Neglected Tropical Diseases|March 29, 2024
Mixed methods to evaluate knowledge, attitudes and practices (KAP) towards rabies in central and remote communities of Moramanga district, MadagascarClaire Leblanc, Daouda Kassié, Mendrika Ranaivoharimina, et al.The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|October 17, 2008
Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionalsPierre Côté, Jean-Guy Baril, Marie-Nicole Hébert, et al.Trials|August 19, 2020
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trialRindra Vatosoa Randremanana, Mihaja Raberahona, Mamy Jean de Dieu Randria, et al.Viruses|August 28, 2021
The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002-2020)Bluma G Brenner, Ruxandra-Ilinca Ibanescu, Nathan Osman, et al.Pageof 80